Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia

Abstract

Guideline changes driven through an AMS initiative involving paediatric oncology patients significantly improved targeted- and nontargeted-antimicrobial use potentially reducing the risk of emergence of resistance against gentamicin in this cohort.